The US Supreme Court has temporarily restored access to the abortion medication mifepristone while legal challenges continue. The court's order represents a temporary pause in the legal battle over the drug's availability.
Mifepristone is used in combination with another medication for medication abortions, which account for more than half of all abortions in the United States. The drug has been at the center of legal challenges since the Supreme Court's 2025 decision that allowed states to impose new restrictions on abortion.
The temporary restoration comes after a lower court ruling that would have severely restricted access to the medication. Advocates for reproductive rights welcomed the Supreme Court's intervention, while opponents vowed to continue their legal challenges.
The case highlights the ongoing national debate about reproductive rights following the 2025 Supreme Court decision. Several states have enacted near-total bans on abortion, while others have moved to protect and expand access.
Legal experts expect the Supreme Court to hear arguments on the merits of the case later this year, with a final decision likely in 2027.